Therapixel raised €15M in a Series B round in May 2022. The company is based in Biot, France. Investors in the round: CapHorn Invest, Crédit Mutuel Innovation, IT-Translation and 5 others. Data as of 6 Aug 2026.
Reported in EUR — no conversion. €15M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
